Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Mankind Pharma Ltd. ( (IN:MANKIND) ) is now available.
Mankind Pharma Ltd. announced that the penalty of ₹2,90,70,363 imposed by the CGST Commissionerate, Meerut, for the financial years 2017-18 to 2021-22, has been withdrawn following an appeal. This development is likely to have a positive impact on the company’s financial standing and may enhance its reputation among stakeholders by demonstrating effective legal and regulatory compliance.
More about Mankind Pharma Ltd.
Mankind Pharma Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of a wide range of pharmaceutical products. The company is known for its commitment to providing affordable healthcare solutions and has a significant market presence in India.
Average Trading Volume: 19,257
Technical Sentiment Signal: Strong Buy
Current Market Cap: 1064.3B INR
Find detailed analytics on MANKIND stock on TipRanks’ Stock Analysis page.